EP3125851B1 - Utilisation d'un récipient pour la conservation de comprimés contraceptifs - Google Patents

Utilisation d'un récipient pour la conservation de comprimés contraceptifs Download PDF

Info

Publication number
EP3125851B1
EP3125851B1 EP15713188.9A EP15713188A EP3125851B1 EP 3125851 B1 EP3125851 B1 EP 3125851B1 EP 15713188 A EP15713188 A EP 15713188A EP 3125851 B1 EP3125851 B1 EP 3125851B1
Authority
EP
European Patent Office
Prior art keywords
tablet
container
blisters
tablets
blister
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15713188.9A
Other languages
German (de)
English (en)
Other versions
EP3125851A1 (fr
Inventor
Hubert Bensmann
Karl-Heinz BANNEFELD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus GmbH
Haupt Pharma Muenster GmbH
Original Assignee
Madaus GmbH
Haupt Pharma Muenster GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus GmbH, Haupt Pharma Muenster GmbH filed Critical Madaus GmbH
Publication of EP3125851A1 publication Critical patent/EP3125851A1/fr
Application granted granted Critical
Publication of EP3125851B1 publication Critical patent/EP3125851B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
    • B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/16—Holders for containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers

Definitions

  • the present invention relates to the use of a container for storing contraceptive pills.
  • Tablets are usually sold in so-called blister packs.
  • Blister packs are product packs that allow the customer or buyer to see the packaged item.
  • the number of tablets per blister can vary depending on the indication and the size of the individual tablets.
  • tablets that need to be taken regularly are often provided in special blister packs that support compliance with a regular intake regime by means of printing, arrangement, etc.
  • An example of corresponding blister packs are tablet blisters for contraceptives.
  • blister packs usually have either 21 or 28 tablets.
  • the 21 tablets or the 21 tablets of the 28 tablets contain a combination of estrogen and progestin, resulting in a regular cycle by taking either no tablet or a drug-free tablet for 7 days after 21 days of tablet intake.
  • the last option is that - for the sake of simplicity - one pill is taken each day and the taking break does not inadvertently last longer than 7 days, which would eliminate protection from conception.
  • WO 2005/023657 A in which a container for a plurality of blister packs is described.
  • the blister packs are releasably fixed on a rail provided in the container.
  • Corresponding containers which as a rule consist of a plastic, are expensive to manufacture and relatively large, so they are considered unwieldy by the patients.
  • these packages are environmentally critical because of the plastic material used.
  • WO 2013/160850 A describes a tablet package, which is designed in the form of a booklet, in which individual tablet blisters are introduced in the form of a magazine page.
  • a disadvantage of this tablet packaging is the size of the tablet packaging, since the individual tablets of tablet blisters are one above the other.
  • the package after use ie removal of a tablet, not resealable.
  • a similar package for a variety of tablet blisters is also from the WO 2009/145932 A known.
  • EP 0 210 820 A2 describes a tablet package which is formed from a rectangular cardboard strip by folding, wherein between two portions of the cardboard strip, a blister is arranged with contraceptive tablets for a single, normal cycle.
  • a container which comprises three interconnected tablet blisters and is formed from two rectangular cardboard strips, between which the three tablet blisters are arranged such that the rows of tablets are substantially parallel to each other, between the respective tablet blisters two folds are provided so that in the opened state the tablets blisters can be arranged side by side in the plane defined by the tablets blister and in the closed state the tablets blisters can be arranged vertically one above the other with substantially parallel alignment of the tablet blisters, each tablet blister four rows of tablet chambers each having seven tablet chambers and the rows are spaced apart from each other in such a way that between two adjacent rows, a numerical imprint can be attached or is.
  • the container may be opened or closed to remove a tablet from one of the tablet blisters.
  • the tablet blisters of the container can be in a plane defined by the rectangular shape of the container Tablets blister is clamped, can be arranged.
  • the open condition of the container is in the FIG. 1 shown during the closed state of the container in Figure 2c and FIG. 4 is shown.
  • the tablet blisters lie vertically one above the other with essentially parallel alignment of the tablet blisters.
  • the container comprises three tablet blisters which are arranged between the two cardboard strips. Two folds are respectively provided between the respective tablet blisters, so that in the opened state the tablet blisters can be arranged side by side in the plane defined by the tablet blister and in the closed state the tablet blisters can be arranged vertically one above the other with essentially parallel alignment of the tablet blisters.
  • the respective tablet blisters each have 28 tablet chambers for receiving tablets for contraception.
  • Each of the 28 tablet chambers of the three tablet blisters are arranged in 4 rows of 7 tablet chambers each.
  • the respective four rows of the three tablet blisters are spaced apart from each other in such a way that a numerical imprint can be placed on the upper cardboard strip between two respectively adjacent rows of tablet chambers of a tablet blister.
  • the individual tablet chambers of the first tablet blister be numbered 1 to 28.
  • the tablet chambers of the second tablet blister be numbered from 29 to 56.
  • the tablet chambers of the third tablet blister be numbered 57-84.
  • tablet blisters are used in the container.
  • Corresponding tablet blisters are known per se to the person skilled in the art and usually comprise an aluminum-containing cover film provided with an adhesive layer, and a base film or thermoforming film, usually made of PVC, in which the tablet chambers are formed by deep drawing.
  • FIGS. 1 and 3 show a container 1 in the open state.
  • FIG. 2 shows the closing of the container 1 from the open state FIG. 2a about a folded state FIG. 2b to a closed state Figure 2c ,
  • FIG. 4 shows a closed container 1 with staggered tablet chambers 11 in the blisters 3 and 4.
  • the FIG. 1 shows a container 1.
  • the three tablets blister 2, 3, 4 are arranged such that the rows of tablets of the respective tablets blister 2, 3, 4 parallel to each other.
  • the tablet blisters 2, 3, 4 are between two cardboard strips 5, 6, seen from the FIGS. 2a to 2c arranged, which extend laterally over the tablet blister 2, 3, 4 and over the area between the tablet blisters 2, 3, 4. Outside the areas of the tablet blister 2, 3, 4, the cardboard strips 5, 6 are connected to each other, in particular glued.
  • the upper cardboard strip 5 has recesses 22 for the tablet chambers of the respective tablet blister 2, 3, 4.
  • the cardboard strips have partial regions 13, 14, 15 which are assigned to the respective tablet blisters 2, 3, 4. Between these portions 13, 14, 15 are each two folds 7, 8, 9, 10, which are formed as folded edges. At these folds or folding edges 7, 8, 9, 10, the container 1 can be folded so that the three tablets blister 2, 3, 4 either side by side in a plane which is spanned by the rectangular shape of the tablet blister 2, 3, 4 (Open state of the container 1), or vertically above one another with substantially parallel alignment of the tablet blister 2, 3, 4 can be arranged (closed state of the container 1).
  • the cardboard strip can have a further partial region 16, which adjoins the partial region 13 in the longitudinal direction. Attachment information, stickers or the like can be attached to the subarea 16.
  • the portions 13, 14, 15, 16 all have a substantially identical surface, so that when folding the container 1 along the folds 7, 8, 9, 10 as in FIGS. 2a to 2c represented, a carton-like shaped body in cuboid shape results.
  • the container 1 has sufficient space for numbering by numeric printing 12 of the corresponding tablets of the respective tablet blister 2, 3, 4.
  • each tablet blister 2, 3, 4 consists of 28 tablets, each arranged in 4 rows of 7 tablets.
  • the tablet blister 2 which is in the partial area 13 is provided, the tablets numbered 1 to 28 from top left to on the lower right.
  • the tablets 29 to 56 which are provided in the tablet blister 3 in the partial region 14, and the tablets 57 to 84 which are provided in the tablet blister 4 in the partial region 15, also from top left to bottom right.
  • This embodiment is in FIG. 1 shown.
  • the tablet blister 4 in the partial region 15 contains the tablets 1 to 28, the tablet blister 3 in the partial region 14, the tablets 29 to 56 and the tablet blister 2 in the partial region 13 the tablets 57 to 84, likewise from top left to bottom right.
  • the tablets 1 to 28 of the tablet blister 4 are first taken by the patient. If the tablets 1 to 28 of the tablet blister 4 are used up, the patient can detach the tablet blister 4 in the partial area 15 along a perforation provided between the tablet blisters 4 and 3 and only needs the tablet blisters 2 and 3 for the remaining revenue regimen to 56 of the tablet blister 3 can then also the portion 14 are separated along the provided between the sections 12 and 13 perforation. As a result, the patient does not have to permanently use the tablet blister 2, 3, 4.
  • the perforations provided for separating the partial regions 14, 15 with the tablet blisters 3, 4 may be provided on the folds 7, 8, 9, 10 or separately therefrom.
  • the order of the individual contraceptive tablets is rotated on each tablet blister by 180 °, so that the weekly series are arranged with 7 tablets in a consistent order 1 to 12. This arrangement of the tablets represents a safe intake by the patient.
  • the container 1 comprises, as already stated, two cardboard strips 5, 6, between which the tablet blisters 2, 3, 4 are introduced.
  • a cardboard or cardboard strip is understood to be any paperboard, paper or plastic material which gives the container 1 sufficient stability.
  • the cardboard strips 5, 6 are integrally formed on both sides of the tablet blisters, wherein said folds 7, 8, 9, 10, 17, 18 are provided between the individual portions 13 to 16 and between the respective portions 14 and 15, which correspond to the tablet blisters 3 and 4, perforations are provided.
  • the cardboard strip 5 is integrally formed and the cardboard strip 6 is composed of three or four individual cardboard strips corresponding to the subregions 13, 14, 15 or 13, 14, 15, 16.
  • only the cardboard strip 6 is integrally formed and the cardboard strip 5 is composed of three or four individual cardboard strips corresponding to the subregions 13, 14, 15 or 13, 14, 15, 16.
  • the arrangement of the tablets in the tablet blisters 3 and 4 in the subregions 14 and 15 is preferably offset so that when the container 1 is folded, the tablets of the tablet blister 4 lie in the spaces between the tablets of the tablet blister 3.
  • the webs 19, 20, 21 can be reduced between the subregions 13 to 16 and the space requirement of the container 1 in the closed state is reduced overall.
  • a corresponding embodiment of the container 1 is in FIG. 4 shown.
  • the cardboard strips on the side of the base films of the tablet blisters 2, 3, 4 have recesses 11 corresponding to the tablet compartments.
  • the portion 16 has at least seven removable, re-attachable strips 23, each identifying the seven days of the week and each beginning with a different day of the week.
  • three sets of 7 adhesive strips each are located on the partial region 16, so that in each case 3 adhesive strips begin on the same day of the week and the corresponding adhesive strips are then respectively attached above the tablet blisters 2, 3, 4.
  • the partial region 16 is provided with a tongue 24, with which the container 1 is closed after folding in the partial regions 13, 14, 15 adjoining the partial region 16 by introduction into a corresponding recess 26, for example in the fold 8 can be.
  • the container 1 has a seal which is such that only by visible destruction of the seal, the tongue 24 can be removed from the recess 26.
  • the production of the container 1 was carried out in such a way that a cardboard strip 5 with recesses 22 and an adhesive coating applied on the back is provided in a first method step, a cardboard strip 6 of the same size is provided in a second method step and in a third method step the two cardboard strips 5, 6 with simultaneous fixation of the tablet blisters 2, 3, 4 connected to each other, in particular glued be.
  • the folds 7 to 10 and 17 and 18 and the optionally provided perforations between the subregions 13 to 15 in the region of the webs 19, 20, 21 can in this case on the cardboard strips 5, 6 before merging the cardboard strips 5, 6 or subsequently after merging the cardboard strip 5, 6 are provided.
  • the Perforations can also be provided on the folds 7, 8, 9, 10.
  • FIG. 5 shows a commercial blister 2, 3, 4 with tablet chambers 11, which are used in the container 1.
  • FIG. 6 shows the modular structure of the container 1.
  • a cardboard strip 6 On a cardboard strip 6 three tablets blister 2, 3, 4 are arranged and provided with a corresponding recesses cardboard strip 5 is fixed on the tablet blister on the cardboard strip 6.
  • the container 1 is particularly suitable for storing contraceptive tablets, which are taken over a longer period of time, for example, 12 weeks.
  • FIGS. 1 . 3a and 3b illustrated container provided with a total of 84 tablet chambers.
  • the container additionally contains 7 placebo tablets. Therefore, the container preferably each has the third tablet blister with 35 tablet compartments instead of 28 tablet compartments.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)

Claims (9)

  1. Utilisation d'un récipient (1) qui comprend trois plaquettes de comprimés reliées entre elles (2, 3, 4) et comprend deux bandes rectangulaires en carton (5, 6), entre lesquelles les trois plaquettes de comprimés (2, 3, 4) sont agencées de manière à ce que les rangées de comprimés des plaquettes de comprimés (2, 3, 4) sont substantiellement parallèles, dans lequel entre les plaquettes respectives de comprimés (2, 3, 4) dans chaque cas deux plis (7, 8, 9, 10) sont fournis, de sorte que dans la position ouverte les plaquettes de comprimés (2, 3, 4) peuvent être disposées côte à côte dans le plan défini par les plaquettes de comprimés (2, 3, 4) ; et dans la position fermée les plaquettes de comprimés (2, 3, 4) peuvent être disposées verticalement l'une au-dessus de l'autre avec un alignement sensiblement parallèle des plaquettes de comprimés (2, 3, 4), dans lequel chaque plaquette de comprimés (2, 3, 4) a quatre rangées de chambres de comprimés (11) chacune avec sept chambres de comprimés (11), et les rangées sont espacées les unes des autres parallèlement de manière à ce qu'entre deux rangées adjacentes, une impression numérique (12) est fixée ou peut l'être, pour le stockage de comprimés contraceptifs.
  2. Utilisation d'un récipient (1), selon la revendication 1, caractérisé en ce que les bandes en carton (5, 6) sont intégralement formées.
  3. Utilisation d'un récipient (1), selon la revendication 1 ou 2, caractérisé en ce que les bandes en carton (5, 6) s'étendent latéralement au-delà des plaquettes de comprimés (2, 3, 4) et sur la région entre les plaquettes de comprimés (2, 3, 4).
  4. Utilisation d'un récipient (1), selon la revendication 3, caractérisé en ce que hors des régions des plaquettes de comprimés (2, 3, 4), les bandes en carton (5, 6) sont connectées, en particulier collées, les unes aux autres.
  5. Utilisation d'un récipient (1), selon l'une quelconque des revendications 1 à 4, caractérisé en ce qu'une bande supérieure en carton (5) comprend des renfoncements (22) pour les chambres de comprimés des plaquettes respectives de comprimés (2, 3, 4).
  6. Utilisation d'un récipient (1), selon l'une quelconque des revendications 1 à 5, caractérisé en ce que les bandes en carton (5, 6) sont divisées en au moins trois zones partielles (13, 14, 15), en particulier, une première (13), une deuxième (14) et une troisième (15) zone partielle, toutes parmi celles-ci correspondent aux plaquettes de comprimés (2, 3, 4).
  7. Utilisation d'un récipient (1), selon la revendication 6, caractérisé en ce que les bandes en carton (5, 6) comprennent une autre zone partielle (16), qui jouxte la première zone partielle (13) dans la direction longitudinale.
  8. Utilisation d'un récipient (1), selon la revendication 7, caractérisé en ce que des autocollants, des dépliants des instructions ou similaires sont fixés sur l'autre zone partielle (16).
  9. Utilisation d'un récipient (1), selon l'une quelconque des revendications 6 à 8, caractérisé en ce que les zones partielles (13, 14, 15, 16) comprennent toutes une surface sensiblement identique, de sorte que lorsque le récipient (1) est plié le long des plis (7, 8, 9, 10, 17, 18), le résultat donne un corps formé de type carton sous forme cuboïde.
EP15713188.9A 2014-03-31 2015-03-27 Utilisation d'un récipient pour la conservation de comprimés contraceptifs Active EP3125851B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014205944 2014-03-31
PCT/EP2015/056723 WO2015150259A1 (fr) 2014-03-31 2015-03-27 Récipient de conservation de comprimés

Publications (2)

Publication Number Publication Date
EP3125851A1 EP3125851A1 (fr) 2017-02-08
EP3125851B1 true EP3125851B1 (fr) 2018-11-28

Family

ID=52779657

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15713188.9A Active EP3125851B1 (fr) 2014-03-31 2015-03-27 Utilisation d'un récipient pour la conservation de comprimés contraceptifs

Country Status (3)

Country Link
EP (1) EP3125851B1 (fr)
ES (1) ES2706278T3 (fr)
WO (1) WO2015150259A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036727A1 (fr) * 1997-02-19 1998-08-27 Ehrensvaerd Jakob Detecteur de distribution de medicament
US20080093253A1 (en) * 2006-10-23 2008-04-24 Gail Halko Medication Dispensing Package
WO2013128459A1 (fr) * 2012-03-01 2013-09-06 2P2D Solutions Ltd. Chaîne blister repliée, machine de pliage et procédé de pliage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518828D0 (en) * 1985-07-25 1985-08-29 American Home Prod Tablet package
US5954202A (en) * 1996-06-28 1999-09-21 Westvaco Corporation Paperboard blank for a self-contained, reclosable package
US7726480B2 (en) * 2005-08-24 2010-06-01 Winterborne, Inc. Display pack and packaging method and apparatus
US7896161B2 (en) * 2008-01-15 2011-03-01 Anderson Packaging, Inc. Child-resistant, senior friendly carded package and method of assembly

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036727A1 (fr) * 1997-02-19 1998-08-27 Ehrensvaerd Jakob Detecteur de distribution de medicament
US20080093253A1 (en) * 2006-10-23 2008-04-24 Gail Halko Medication Dispensing Package
WO2013128459A1 (fr) * 2012-03-01 2013-09-06 2P2D Solutions Ltd. Chaîne blister repliée, machine de pliage et procédé de pliage

Also Published As

Publication number Publication date
EP3125851A1 (fr) 2017-02-08
ES2706278T3 (es) 2019-03-28
WO2015150259A1 (fr) 2015-10-08

Similar Documents

Publication Publication Date Title
EP1947027B1 (fr) Habillage transparent et procédé de stockage temporaire de produits
DE10030318C1 (de) Arzneimittelverpackung für die Eradikationstherapie
EP0718208B1 (fr) Emballage de type blister
EP1898863B1 (fr) Etui pour recevoir un emballage de medicament et utilisation associee
DE202004021140U1 (de) Neue Arzneimittelverpackung
DE4429503A1 (de) Packung, insbesondere Arzneimittelpackung, und Verfahren zur Herstellung der Packung
EP2393466A1 (fr) Dispositif et son utilisation pour la conservation et la mise à disposition de médicaments sous forme stratifiée
EP1353857A1 (fr) Unite d'emballage primaire destinee a plusieurs comprimes pellicules individuels en tant que formes pharmaceutiques
DE202018107039U1 (de) Hygieneartikelprodukt
EP1964788A1 (fr) Emballage-coque à securité de reprise successive
EP3125851B1 (fr) Utilisation d'un récipient pour la conservation de comprimés contraceptifs
DE19957809B4 (de) Verwendung einer Blisterpackung
DE4324771A1 (de) Arzneimittel-Zuteilbehälter
EP4000586A1 (fr) Récipient pour médicaments, ensemble permettant de former un récipient pour médicaments et procédé de fourniture d'un récipient pour médicaments
EP1985550A1 (fr) Unité d'emballage pour médicament et son procédé de fabrication
EP3924267B1 (fr) Emballage doté d'une sécurité enfant
EP3353086A1 (fr) Plaquettes monoalvéolaires pour un empilement optimisé
EP2393467A1 (fr) Procédé pour produire un empilement de pochettes servant à conserver et à mettre à disposition des médicaments sous forme stratifiée, modèle de pochette pour produire ledit empilement et utilisation dudit modèle
DE102017215917A1 (de) Individuelle Blisterverpackung, Verpackungsmaschine und Verfahren zur Herstellung einer individuellen Blisterverpackung
WO2023194545A1 (fr) Emballage de médicament
WO2020193565A1 (fr) Pochette d'emballage pour articles hygiéniques
DE29719070U1 (de) Blister für die Kombinationstherapie
DE102022114007A1 (de) Medikamentenverpackungen
AT517864B1 (de) Überverpackung für Blisterverpackung
DE2233822A1 (de) Musterpackung fuer arzneimittel

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20160914

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20171215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 502015006998

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61J0001030000

Ipc: B65D0083040000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61J 7/04 20060101ALI20180612BHEP

Ipc: B65D 83/04 20060101AFI20180612BHEP

Ipc: A61J 1/03 20060101ALI20180612BHEP

INTG Intention to grant announced

Effective date: 20180713

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1069972

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502015006998

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2706278

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20190328

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190228

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190328

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190228

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190328

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190301

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20190603

Year of fee payment: 5

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502015006998

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

26N No opposition filed

Effective date: 20190829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190327

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20190331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190331

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200327

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 1069972

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20150327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181128

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20240326

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240328

Year of fee payment: 10

Ref country code: GB

Payment date: 20240319

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20240321

Year of fee payment: 10

Ref country code: FR

Payment date: 20240326

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240410

Year of fee payment: 10